RareStone Group is committed to building China's first rare disease ecosystem, providing comprehensive and sustainable support for patients and families affected by rare diseases. Langyu Group currently has two subsidiaries: "Citrine Medicine", which focuses on the R&D and commercialization of rare disease drugs, and "Citrine Medicine", which provides medical solutions for rare disease patients and families."Zircon Health"
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.